Clover Health Investments, Corp. (CLOV) News
Follow Clover Health Investments, Corp. (CLOV) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Clover Health Reports Third-Quarter 2026 Results
Clover Health reported third-quarter 2026 results.
EQUITY | Nov 04, 2026, 09:13 PM UTC
H
Shares of health insurance companies are trading higher the U.S. CMS awarded five- and four-star ratings to plans offered by UnitedHealth Group, Clover, and Humana among others. Also, Humana reaffirmed its FY26 adjusted EPS guidance and issued optimistic comments about FY27 and FY28.
Shares of health insurance companies are trading higher the U.S. CMS awarded five- and four-star ratings to plans offered by UnitedHealth Group, Clover, and Humana among others. Also, Humana reaffirmed its FY26 adjusted
LIVE | Oct 09, 2026, 06:42 PM UTC
M
Clover Health to Report Q3 2026 Results on Nov. 4, 2026
EQUITY | Oct 07, 2026, 08:05 PM UTC
L
UPDATE — Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors
WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. NASDAQ:CLOV (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli and
NEWS | Sep 24, 2026, 10:01 PM UTC
L
Senator Robert G. Torricelli and Dr. Brian J. Miller join Clover Health Investments board
Clover Health Investments appointed Senator Robert G. Torricelli and Dr. Brian J. Miller to its Board, filling two vacancies and bringing the board to nine directors.Original SEC Filing: CLOVER HEALTH INVESTMENTS, CORP.
REGULATION | Sep 24, 2026, 08:34 PM UTC
L
Clover Health Investments, Corp. (CLOV) Adds Two Directors
Clover Health Investments, Corp. appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its Board, filling two vacancies and bringing the Board to nine directors. Torricelli joins the Audit Committee;
NEWS | Sep 24, 2026, 08:32 PM UTC
L
Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors
WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. NASDAQ:CLOV (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli and
NEWS | Sep 24, 2026, 08:32 PM UTC
L
Clover Health Names U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Bd of Directors
Clover Health Names U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Bd of Directors
NEWS | Sep 24, 2026, 08:30 PM UTC
L
Clover Health shares jump 8.5% after Deutsche Bank starts coverage
Clover Health shares rose 8.5% in the afternoon session after Deutsche Bank initiated coverage with a Buy rating and a $6.00 price target. Analyst George Hill highlighted key drivers behind the view.
EQUITY | Sep 10, 2026, 07:43 PM UTC
L
Clover Health to Participate in Upcoming Investor Conferences
Clover Health to Participate in Upcoming Investor Conferences
EQUITY | Aug 31, 2026, 08:07 PM UTC
L
CLOV - Clover Health to Participate in Upcoming Investor Conferences
CLOV - Clover Health to Participate in Upcoming Investor Conferences
EQUITY | Aug 31, 2026, 08:05 PM UTC
H
Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Thursday. Shares of Motorola Solutions In c (NYSE: MSI ) rose sharply after the company reported better-than-expected second-quarter financial
EARNINGS | Aug 06, 2026, 02:01 PM UTC
L
Clover Health Investments Raises FY2026 Sales Guidance from $2.810B-$2.920B to $2.920B-$3.000B vs $2.910B Est
Clover Health Investments (NASDAQ: CLOV ) raises FY2026 sales outlook from $2.810 billion-$2.920 billion to $2.920 billion-$3.000 billion vs $2.910 billion estimate.
EARNINGS | Aug 05, 2026, 08:30 PM UTC
L
CLOV Q2 2026: Net income $28m Revenue $743m, up 56% YoY MA membership 157.3k, up 48% Raised FY26 guidance across all metrics
CLOV Q2 2026: Net income $28m Revenue $743m, up 56% YoY MA membership 157.3k, up 48% Raised FY26 guidance across all metrics
EARNINGS | Aug 05, 2026, 08:18 PM UTC
L
CLOV - Clover Health Reports Second Quarter 2026 Results
CLOV - Clover Health Reports Second Quarter 2026 Results
EARNINGS | Aug 05, 2026, 08:07 PM UTC
L
Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit
Elevance Health Inc. (NYSE: ELV ) has sued the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS), alleging the agencies unlawfully applied different standards to Me
GEOPOLITICS | Jul 06, 2026, 02:02 PM UTC